NCT01376271已完成不适用
Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 600
- 主要终点
- The number of adverse events in Japanese subjects with social anxiety disorder treated with paroxetine tablets
研究概览
简要总结
The study is designed to evaluate the safety and efficacy of paroxetine on the long-term use in Japanese Social Anxiety Disorder (SAD) subjects.
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who are diagnosed as having SAD
- •Subjects who are expected to use paroxetine tablets for the first time
排除标准
- •Subjects taking pimozide
- •Subjects taking monoamine oxidase (MAO) inhibitor or within two weeks after discontinuation of MAO inhibitor
- •Subjects with hypersensitivity to paroxetine
研究组 & 干预措施
Subjects prescribed paroxetine tablets
Subjects with SAD prescribed paroxetine tablets during study period
干预措施: Paroxetine (Drug)
结局指标
主要结局
The number of adverse events in Japanese subjects with social anxiety disorder treated with paroxetine tablets
时间窗: 1 year
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)Panic DisorderNCT01371474GlaxoSmithKline1,483
已完成
不适用
Special Drug Use Investigation for PAXIL Tablet (Long-term)Mental DisordersNCT01371448GlaxoSmithKline339
已完成
不适用
Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)Panic DisorderNCT01376128GlaxoSmithKline96
已完成
不适用
Drug Use Investigation for PAXIL TabletMental DisordersNCT01371435GlaxoSmithKline3,708
已完成
不适用
Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)Mental DisordersNCT01371461GlaxoSmithKline390